FAT BURNERS (58 Offers)
Dragon Pharma Fat Burners offer a strategic range of thermogenic and lipolytic compounds for advanced research. This selection includes powerful agents like Clenbuterol and Ephedrine, designed to support metabolic rate and fat mobilization when combined with proper diet and training protocols.
Drug Class: Growth Hormone Fragment
Composition: AOD9604
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial
Brand: Dragon Pharma
For Subcutaneous Injection
Drug Class: Amino Acid Derivative, Fat Transport Agent
Composition: Levocarnitine (L-Carnitine Base)
Dosage: 500 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Mitochondrial-Derived Peptide (MDP)
Composition: Mitochondrial Open Reading Frame of the 12S rRNA-c
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Injectable Use After Reconstitution
Drug Class: Dual GLP-1 and Glucagon Receptor Agonist
Composition: Mazdutide (IBI362)
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Triple GIP, GLP-1 & Glucagon Receptor Agonist
Composition: Retatrutide (LY3437943)
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist
Composition: Semaglutide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection After Reconstitution
Drug Class: Dual GIP and GLP-1 Receptor Agonist
Composition: Tirzepatide
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
Drug Class: Dual GIP and GLP-1 Receptor Agonist
Composition: Tirzepatide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
For Subqutaneous Injection
Composition: Semaglutide GLP-1 RA
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial
Manufactured by Kalpa Pharmaceuticals
For Subqutaneous Injection
Composition: Tirzepatide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial
Manufactured by Kalpa Pharmaceuticals
Drug Class: GLP-1 Receptor Agonist
Composition: Semaglutide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Peptide Hubs
Laboratory Test: View Lab Report
For Subcutaneous Injection
Drug Class: GIP/GLP-1 Dual Receptor Agonist
Composition: Tirzepatide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Peptide Hubs
Laboratory Test: View Lab Report
For Subcutaneous Injection
Drug Class: Beta-2 Adrenergic Agonist
Composition: Clenbuterol Hydrochloride
Dosage: 40 mcg/tablet
Form: Oral Tablet
Unit: 100 Tablets
Brand: British Dragon
Laboratory Test: View Lab Report
For Oral Administration
Drug Class: Thermogenic Compound / Fat Burner
Composition:
- Clenbuterol 37 mcg
- T3 25 mcg
- Yohimbine 5.4 mg
Dosage: 6.02 mg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
For Oral Administration
Drug Class: Beta-2 Adrenergic Agonist
Composition: Clenbuterol Hydrochloride
Dosage: 40 mcg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Oral Administration
Drug Class: Beta-2 Agonist & Alpha-2 Antagonist
Composition:
- Clenbuterol HCl 80 mcg
- Yohimbine HCl 5 mg
Dosage: 5.8 mg/ml
Form: Injectable Solution
Unit: 10 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous or Intramuscular Administration
Dragon Pharma Fat Burners: Advanced Metabolic Research Compounds
Breaking through plateaus in body composition requires a multi-faceted approach. Dragon Pharma Fat Burners provide researchers with a selection of compounds that target fat loss through various physiological mechanisms. From powerful thermogenic agents to lipolytic compounds, this category is designed for those studying advanced strategies for metabolic acceleration and adipose tissue reduction.
Understanding Thermogenic and Lipolytic Mechanisms
Fat burning compounds generally work through one of two primary pathways: thermogenesis or lipolysis. Thermogenic agents like Clenbuterol and Ephedrine increase core body temperature and metabolic rate, causing the body to burn more calories at rest. Lipolytic compounds like Yohimbine and L-Carnitine work to enhance the breakdown and transport of fatty acids from fat cells to be used as energy by the body.
Key Compounds and Their Research Applications
The Dragon Pharma catalog includes both well-established and emerging compounds for metabolic research, each with distinct properties and mechanisms of action.
- Clenbuterol: A potent beta-2 agonist known for its strong thermogenic effects and ability to increase metabolic rate significantly.
- Ephedrine: Works as a central nervous system stimulant that promotes thermogenesis and appetite suppression.
- Yohimbine: An alpha-2 antagonist particularly effective at targeting stubborn fat areas by increasing blood flow to adipose tissue.
- L-Carnitine: Functions as a transport molecule that shuttles fatty acids into the mitochondria for energy production.
- Ketotifen: An antihistamine used in research to help manage beta-2 receptor downregulation from prolonged Clenbuterol use.
- SLU-PP-332: An emerging research compound that activates ERRγ, potentially increasing metabolic rate and endurance.
Synergistic Protocols and Cycling Strategies
Many researchers find that combining compounds with complementary mechanisms can yield enhanced results. For instance, pairing a thermogenic like Clenbuterol with a lipolytic agent like Yohimbine may provide a more comprehensive fat-loss approach. However, proper cycling is crucial—most thermogenic compounds require periodic breaks to maintain receptor sensitivity and prevent tolerance buildup. Ketotifen, for example, is often researched alongside Clenbuterol protocols for its potential to extend effective use.
Safety Considerations in Metabolic Research
Working with potent metabolic agents requires careful attention to dosage and individual tolerance. Many fat-burning compounds can affect heart rate, blood pressure, and electrolyte balance. Researchers should start with conservative dosages and closely monitor physiological responses. Proper hydration and electrolyte management are essential, particularly with thermogenic compounds that can increase perspiration and mineral excretion.
